Literature DB >> 23617747

Overexpressions of microRNA-9 and microRNA-200c in human breast cancers are associated with lymph node metastasis.

Jincai Wang1, Hong Zhao, Dabei Tang, Jin Wu, Guodong Yao, Qingyuan Zhang.   

Abstract

PURPOSE: The aim of this study was to investigate the relationship between the expressions of microRNA-9 (miR-9) and microRNA-200c (miR-200c) in human breast cancers and clinicopathological features.
METHODS: We investigated the expressions of miR-9 and miR-200c in 68 patients with breast cancers using the quantitative reverse transcription-polymerase chain reaction method, and assessed the E-cadherin status using the immunohistochemistry method.
RESULTS: The relative expression levels of miR-9 and miR-200c in breast cancer patients with lymph node metastasis were higher than that of patients without lymph node metastasis. The expression of miR-9 correlated inversely with E-cadherin expression.
CONCLUSIONS: The results showed that higher expressions of miR-9 and miR-200c in human breast cancers were associated with lymph node metastasis. This study indicated that the elevation of miR-9 and miR-200c in human breast cancers can induce an invasive phenotype and may serve as a molecular diagnostic marker for patients with breast cancer.

Entities:  

Keywords:  E-cadherin; breast cancer; metastasis; microRNA-200c; microRNA-9

Mesh:

Substances:

Year:  2013        PMID: 23617747      PMCID: PMC3653379          DOI: 10.1089/cbr.2012.1293

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  20 in total

1.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways.

Authors:  Tamer T Onder; Piyush B Gupta; Sendurai A Mani; Jing Yang; Eric S Lander; Robert A Weinberg
Journal:  Cancer Res       Date:  2008-05-15       Impact factor: 12.701

Review 2.  Molecular requirements for epithelial-mesenchymal transition during tumor progression.

Authors:  Margit A Huber; Norbert Kraut; Hartmut Beug
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

3.  MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.

Authors:  Clemens L Bockmeyer; Matthias Christgen; Mirco Müller; Sebastian Fischer; Philipp Ahrens; Florian Länger; Hans Kreipe; Ulrich Lehmann
Journal:  Breast Cancer Res Treat       Date:  2011-03-17       Impact factor: 4.872

4.  MicroRNA gene expression deregulation in human breast cancer.

Authors:  Marilena V Iorio; Manuela Ferracin; Chang-Gong Liu; Angelo Veronese; Riccardo Spizzo; Silvia Sabbioni; Eros Magri; Massimo Pedriali; Muller Fabbri; Manuela Campiglio; Sylvie Ménard; Juan P Palazzo; Anne Rosenberg; Piero Musiani; Stefano Volinia; Italo Nenci; George A Calin; Patrizia Querzoli; Massimo Negrini; Carlo M Croce
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

5.  Altered MicroRNA expression in cervical carcinomas.

Authors:  Jeong-Won Lee; Chel Hun Choi; Jung-Joo Choi; Young-Ae Park; Seung-Jun Kim; Seung Yong Hwang; Woo Young Kim; Tae-Joong Kim; Je-Ho Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

6.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.

Authors:  Sun-Mi Park; Arti B Gaur; Ernst Lengyel; Marcus E Peter
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

Review 7.  Micromanagers of malignancy: role of microRNAs in regulating metastasis.

Authors:  Li Ma; Robert A Weinberg
Journal:  Trends Genet       Date:  2008-07-31       Impact factor: 11.639

8.  Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.

Authors:  Gregory J Hurteau; J Andrew Carlson; Simon D Spivack; Graham J Brock
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

9.  The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.

Authors:  Qihong Huang; Kiranmai Gumireddy; Mariette Schrier; Carlos le Sage; Remco Nagel; Suresh Nair; David A Egan; Anping Li; Guanghua Huang; Andres J Klein-Szanto; Phyllis A Gimotty; Dionyssios Katsaros; George Coukos; Lin Zhang; Ellen Puré; Reuven Agami
Journal:  Nat Cell Biol       Date:  2008-01-13       Impact factor: 28.824

Review 10.  Host microenvironment in breast cancer development: epithelial-mesenchymal transition in breast cancer development.

Authors:  Anne Vincent-Salomon; Jean Paul Thiery
Journal:  Breast Cancer Res       Date:  2003-02-03       Impact factor: 6.466

View more
  20 in total

1.  Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma.

Authors:  Zhenyu Wu; Liang Wang; Gang Li; Hui Liu; Feiyan Fan; Zhaobo Li; Yunqing Li; Guodong Gao
Journal:  Mol Cell Biochem       Date:  2013-12       Impact factor: 3.396

2.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

Review 3.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

4.  MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2.

Authors:  Guodong Xu; Guofeng Shao; Qiaoling Pan; Lebo Sun; Dawei Zheng; Minghui Li; Ni Li; Huoshun Shi; Yiming Ni
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

5.  An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer.

Authors:  Xin Zhou; Xiaping Wang; Zebo Huang; Lei Xu; Wei Zhu; Ping Liu
Journal:  J Exp Clin Cancer Res       Date:  2014-11-06

6.  MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.

Authors:  D-Z Liu; B Chang; X-D Li; Q-H Zhang; Y-H Zou
Journal:  Clin Transl Oncol       Date:  2017-04-10       Impact factor: 3.405

Review 7.  Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings.

Authors:  Sachin Kumar Deshmukh; Sanjeev K Srivastava; Nikhil Tyagi; Aamir Ahmad; Ajay P Singh; Ahmed A L Ghadhban; Donna L Dyess; James E Carter; Kari Dugger; Seema Singh
Journal:  Carcinogenesis       Date:  2017-08-01       Impact factor: 4.944

8.  MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.

Authors:  Jingchang Sun; Kunpeng Fang; Hang Shen; Yeben Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Circulating microRNAs - a new horizon in molecular diagnosis of breast cancer.

Authors:  Hoda A Hagrass; Samar Sharaf; Heba F Pasha; Enas A Tantawy; Randa H Mohamed; Rasha Kassem
Journal:  Genes Cancer       Date:  2015-05

10.  Overexpression of miR-9 in mast cells is associated with invasive behavior and spontaneous metastasis.

Authors:  Joelle M Fenger; Misty D Bear; Stefano Volinia; Tzu-Yin Lin; Bonnie K Harrington; Cheryl A London; William C Kisseberth
Journal:  BMC Cancer       Date:  2014-02-11       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.